IRIS
STANZIONE, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.690
AS - Asia 8.219
EU - Europa 5.438
SA - Sud America 751
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 74
OC - Oceania 17
Totale 78.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.421
SG - Singapore 5.500
DE - Germania 1.295
CN - Cina 1.060
UA - Ucraina 865
IT - Italia 631
RU - Federazione Russa 615
BR - Brasile 603
HK - Hong Kong 538
IE - Irlanda 504
FR - Francia 404
VN - Vietnam 371
GB - Regno Unito 319
FI - Finlandia 206
PL - Polonia 200
SE - Svezia 180
KR - Corea 171
BD - Bangladesh 154
CA - Canada 124
JP - Giappone 113
IN - India 62
AR - Argentina 54
NL - Olanda 47
BE - Belgio 39
MX - Messico 38
TR - Turchia 31
AT - Austria 30
IQ - Iraq 30
ID - Indonesia 29
ES - Italia 28
CO - Colombia 27
CR - Costa Rica 26
JM - Giamaica 26
ZA - Sudafrica 26
EC - Ecuador 25
EU - Europa 21
PH - Filippine 20
VE - Venezuela 17
IL - Israele 16
AU - Australia 15
MA - Marocco 13
MY - Malesia 13
NI - Nicaragua 12
PK - Pakistan 12
UZ - Uzbekistan 12
KG - Kirghizistan 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
KE - Kenya 9
NP - Nepal 9
RO - Romania 9
EG - Egitto 8
HN - Honduras 8
LT - Lituania 8
PY - Paraguay 8
TW - Taiwan 8
CH - Svizzera 6
EE - Estonia 6
GT - Guatemala 6
AZ - Azerbaigian 5
DZ - Algeria 5
IR - Iran 5
PA - Panama 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BB - Barbados 4
LB - Libano 4
PT - Portogallo 4
RS - Serbia 4
GE - Georgia 3
GR - Grecia 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
SV - El Salvador 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DM - Dominica 2
ET - Etiopia 2
GP - Guadalupe 2
JO - Giordania 2
KH - Cambogia 2
LU - Lussemburgo 2
NG - Nigeria 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
UY - Uruguay 2
VC - Saint Vincent e Grenadine 2
AG - Antigua e Barbuda 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
Totale 78.194
Salva come PNG Salva come JPEG
Città #
Woodbridge 19.076
Wilmington 15.574
Houston 14.637
Fairfield 1.821
Ann Arbor 1.462
Ashburn 1.376
Singapore 1.303
San Jose 803
Jacksonville 794
Seattle 696
Cambridge 628
Hong Kong 532
Dublin 496
Chandler 487
Beijing 429
Medford 375
Council Bluffs 280
Dearborn 278
Santa Clara 253
The Dalles 203
New York 185
Lawrence 174
Kraków 170
Los Angeles 163
Rome 129
Lauterbourg 126
Hanoi 107
Moscow 106
Dallas 104
Ho Chi Minh City 102
Buffalo 101
San Diego 99
Zhengzhou 94
Tokyo 89
Milan 81
Mülheim 75
Menlo Park 68
São Paulo 66
London 53
Falls Church 51
Chicago 47
Phoenix 36
Brussels 35
Brooklyn 34
Munich 34
Toronto 34
University Park 34
Verona 34
North Bergen 33
Atlanta 31
Helsinki 31
Redondo Beach 31
Detroit 30
Nuremberg 30
Nürnberg 28
Orem 28
Mcallen 27
Boardman 26
Denver 26
Norwalk 25
Montreal 23
Mountain View 23
San José 23
Shanghai 23
Rio de Janeiro 22
Warsaw 22
Chennai 20
Palo Alto 20
San Francisco 20
Washington 20
Kunming 19
St Louis 19
Hefei 18
Manchester 18
Carrboro 17
Miami 17
Philadelphia 17
Columbus 16
Johannesburg 16
Nanjing 16
Stockholm 16
Boston 15
Guangzhou 15
Haiphong 15
Naples 15
Kingston 14
Redwood City 14
Belo Horizonte 13
Brasília 13
Da Nang 13
Guayaquil 13
San Mateo 13
Managua 12
Ankara 11
Charlotte 11
Dhaka 11
Hangzhou 11
Vienna 11
Curitiba 10
Jakarta 10
Totale 64.925
Salva come PNG Salva come JPEG
Nome #
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 629
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 629
Therapy for dyskinesias in Parkinson’s disease patients 626
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 624
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 613
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 609
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 606
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 581
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 578
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 567
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 556
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 554
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 550
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study 547
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 545
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 535
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study 533
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 531
Intra-arterial Thrombectomy versus Standard Intravenous Thrombolysis in Patients with Anterior Circulation Stroke Caused by Intracranial Arterial Occlusions: A Single-center Experience 525
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 520
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 518
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 507
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 505
The role of dopamine receptors on lower urinary tract function in Parkinson's disease patients 501
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 500
Long-term Results of Drug-Eluting Balloon Angioplasty for Treatment of Refractory Recurrent Carotid In-Stent Restenosis 497
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 496
Serial determinations of leukocyte aggregation in patients with ischemic stroke 495
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 494
Effects of L-dopa on urodynamic findings in Parkinson's disease patients: Acute vs. chronic administration 492
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 488
Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis 485
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 484
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 484
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 482
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 482
Spontaneous subarachnoid hemorrhage in an HIV patient 480
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 480
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 478
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 478
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms 478
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 478
Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience. 477
Serial determinations of leukocyte aggregation in patients with ischemic stroke 475
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 474
Collet-Sicard syndrome caused by a coiling of the internal carotid artery 469
Effects of inhibitory rTMS on bladder function in Parkinson's disease patients 469
Cytotoxin-associated gene-A - Positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke 467
Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease 467
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: An effective tool to investigate in vivo GABAergic cortical inhibition in humans 466
Changes in cerebrovascular reactivity following low-frequency repetitive transcranial magnetic stimulation 466
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. 465
Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease 461
Evaluation of basal ganglia haemodynamic changes with perfusion-weighted magnetic resonance imaging in patients with Parkinson's disease 461
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 459
Stroke prevention: managing modifiable risk factors 459
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 459
Encouraging and positive trend towards treatment of acute ischemic stroke performed by vascular interventional radiologist 458
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 458
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 457
Safety of early carotid artery stenting after systemic thrombolysis: a single center experience 456
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease 456
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 456
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy 456
Boundary cerebral infarct in a case of essential thrombocythemia 454
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale 454
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations 454
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 453
Saving the ischemic penumbra: Potential role for statins and phosphodiesterase inhibitors 452
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 452
Ultrasound evaluation of early changes in arterial dissection 451
H. pylori eradication improves L-dopa absorption in patients with Parkinson’s disease 451
Non ulcer dyspepsia is associated with helicobacter pylori infection in patients with Parkinson's disease 451
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 451
An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease 451
Proposal for a Vascular Computed Tomography-Based Grading System in Posterior Circulation Stroke: A Single-Center Experience 451
Urgent carotid endarterectomy: The role of serial ultrasound studies in early detection of plaque rupture 450
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 448
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients 448
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 447
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 447
Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome 447
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 446
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 445
Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients 445
Floating carotid thrombus treated by intravenous heparin and endarterectomy. 443
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 443
Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials 442
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 440
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 440
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 439
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study 438
Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study. 435
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 434
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease 433
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 432
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 430
EPILEPTIC ACTIVITY FOLLOWING CEREBRAL-ISCHEMIA IN MONGOLIAN GERBILS IS DEPRESSED BY CPP, A COMPETITIVE ANTAGONIST OF THE N-METHYL-D-ASPARTATE RECEPTOR 430
Early DEtection of wEaring off in Parkinson disease: the DEEP study 429
Prevalence of patent foramen ovale in ischaemic stroke in italy: Results of SISIFO study 429
Totale 48.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.344 0 0 0 76 59 165 104 71 111 124 119 515
2022/20231.642 225 108 47 186 99 462 156 67 129 9 119 35
2023/2024522 67 21 43 7 43 104 20 59 19 8 8 123
2024/20256.603 110 881 388 209 99 206 270 141 345 262 2.092 1.600
2025/20265.946 459 253 783 466 535 176 683 825 683 603 262 218
2026/20272.670 429 360 1.195 686 0 0 0 0 0 0 0 0
Totale 78.641